Cannasouth + Eqalis Merger
On 1 June 2023 Cannasouth merged with leading medicinal cannabis company Eqalis.
Together we will deliver better outcomes for patients – both locally and globally – by combining IP, technology, research and development, innovation, manufacturing, sales, and prescribing capabilities.
The Cannasouth Group now operates end-to-end with GMP approval for producing dried cannabis flower and manufacturing cannabis-based ingredients and medicinal cannabis products, including oral solutions.
This page contains all information available about the merger.
To view and download the Cannasouth and Eqalis proposed merger fact sheet please click here.
At the Special Shareholder Meeting of Cannasouth Limited (NZX:CBD) held in Auckland on 28 April 2023 at Link Market Services offices and online, shareholders overwhelmingly approved the proposed merger with Eqalis Group New Zealand Limited.
Below are links to documents relating to the Special Shareholder Meeting:
Results of Cannasouth Limited Special Shareholder Meeting
Links to Market Announcements regarding the proposed merger:
1 June 2023 – Share Issue Notification and Post-merger Board Re-constitution
30 May 2023 – Capital Raise Complete, Merger with Eqalis Unconditional
10 May 2023 – Cannasouth Announces Opening of Rights Offer, and new General Retail Offer
1 May 2023 – Launch of capital raising initiatives in support of merger
28 April 2023 – Results of Cannasouth Limited Special Shareholder Meeting
28 April 2023 – Presentation Slides for Cannasouth Special Meeting
13 April 2023 – Notice of Meeting and Capital Raise Firm Commitments
4 April 2023 – Merger Update – Share Sale Deed & Capital Raise
6 March 2023 – Director Nominations Period for Special Shareholder Meeting
27 February 2023 – Eqalis Signs Supply Agreement for Australia
20 February 2023 – Market update regarding prospective merger with Eqalis
19 December 2022 – CBD enters prospective merger arrangement with Eqalis
To visit the Eqalis website, please click here.
To visit the RestoreMe website, please click here.
